VANDEROSTYNE
ActiveSummary
VANDEROSTYNE has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €368,199 and a net result of €41,509. Equity is growing by ~7.7% per year across the filed fiscal years. Its solvency ranks better than 54% of 6032 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
24-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
05-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 5 days late
2023
31-12
Financial
Back to profitnet €25,069
Net result €25,069 after 2 loss-making years.
01-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 1 day late
2022
31-12
Financial
Weakest financial yearnet -€29,796
Net result drops to -€29,796, the lowest in the series; recovery starts the following year.
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
22-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 22 days late
2020
31-12
Financial
Highest result since 2018net €90,826 ▲245%
Operating result €136,167, net result €90,826, both a record.
04-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 4 days late
2019
12-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 12 days late
2018
26-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 26 days late
2017
06-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 6 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.